- Design
- Cluster-randomised controlled trial, 44 communities
- Population
- Community providers and patients in Burkina Faso and DR Congo
- Primary outcome
- Change in Watch-group antibiotic use
- Effect
- Adjusted prevalence ratio 0.33 (95% CI 0.14-0.78)
Rising use of WHO Watch-group antibiotics in community settings drives resistance. CABU-EICO, a cluster-randomised trial in 44 villages in Burkina Faso and DR Congo, tested a co-created behavioural bundle aimed at every level of community provider, from health centres to pharmacies and informal vendors.
Over three rounds across nine months, the intervention combined community health-education campaigns with provider education and feedback built around the WHO AWaRe antibiotic guidance. Watch-group antibiotic use fell from 26.8% to 17.1% in intervention clusters while rising from 13.4% to 21.2% in controls, an adjusted prevalence ratio of 0.33. Patient-management scores from simulated visits were essentially unchanged, so the fall was not at the cost of under-treatment.
The relevance beyond these settings is the model: engaging the whole chain of dispensers, including informal vendors, rather than hospital prescribers alone, can shift community antibiotic use without harming care.
- Cluster-randomised trial in 44 villages in Burkina Faso and DR Congo.
- A behavioural bundle targeted all community dispensers, including informal vendors.
- Watch-group antibiotic use fell from 26.8% to 17.1% with the intervention.
- Use rose from 13.4% to 21.2% in controls (adjusted prevalence ratio 0.33).
- Simulated-patient management scores were unchanged, so care was not compromised.
Why it matters
It shows broad-spectrum community antibiotic use is modifiable outside the hospital, where much of the resistance pressure arises.
The statistics, in plain English
An adjusted prevalence ratio of 0.33 means roughly two-thirds lower odds of Watch-group use after accounting for the opposite trend in controls. The wide confidence interval (0.14 to 0.78) reflects a cluster design with relatively few villages, so the size of the effect is uncertain even though its direction is clear.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for infectious diseases, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free